XML 89 R73.htm IDEA: XBRL DOCUMENT v3.19.1
Commitments and Contingencies (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 53 Months Ended
Apr. 03, 2017
Jan. 31, 2019
Sep. 30, 2018
Feb. 28, 2017
Jan. 31, 2017
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
Jan. 01, 2019
Dec. 31, 2018
Nov. 30, 2014
Commitments                      
Operating lease, liability           $ 7,857   $ 7,857      
Operating lease, right-of-use asset           $ 7,024   $ 7,024      
Weighted average remaining operating lease term           2 years 2 months 1 day   2 years 2 months 1 day      
Weighted average operating lease discount rate           4.63%   4.63%      
Lease cost           $ 1,100          
Operating cash outflows from operating leases           1,200          
Right-of-use asset obtained in exchange for lease obligations           1,000          
Minimum purchase commitments           42,700   $ 42,700      
Contingent consideration paid           $ 17 $ 44        
Velo Bio, LLC | Regulatory Milestone Achievement                      
Commitments                      
Milestone payments     $ 5,000                
Velo Bio, LLC | Regulatory Milestone Achievement, U.S.Food And Drug Administration Approval                      
Commitments                      
Milestone payments     30,000                
Velo Bio, LLC | Annual Sales Milestone Achievements                      
Commitments                      
Milestone payments     240,000                
Velo Bio, LLC | Commercial Milestone Payments                      
Commitments                      
Milestone payments     10,000                
Endoceutics, Inc. | Intrarosa | First Sales Milestone Achievement                      
Commitments                      
Future contingent payments (up to)       $ 15,000              
Potential milestone payment, triggering event, sales       150,000              
Endoceutics, Inc. | Intrarosa | Second Sales Milestone Achievement                      
Commitments                      
Future contingent payments (up to)       30,000              
Potential milestone payment, triggering event, sales       300,000              
Endoceutics, Inc. | Intrarosa | Third Sales Milestone Achievement                      
Commitments                      
Future contingent payments (up to)       850,000              
Potential milestone payment, triggering event, sales       500,000              
Endoceutics, Inc. | Intrarosa | Tiered Royalties                      
Commitments                      
Potential milestone payment, triggering event, sales       $ 150,000              
Royalty percentage, maximum 25.00%     25.00%              
Net sales threshold, future contingent payments       $ 1,000,000              
Period after first commercial sale       10 years              
Palatin Technologies, Inc. | Vyleesi Products | First Sales Milestone Achievement                      
Commitments                      
Future contingent payments (up to)         $ 25,000            
Potential milestone payment, triggering event, sales         250,000            
Palatin Technologies, Inc. | Vyleesi Products | Regulatory Milestone Achievement, U.S.Food And Drug Administration Approval                      
Commitments                      
Future contingent payments (up to)         $ 60,000            
Palatin Technologies, Inc. | Vyleesi Products | Tiered Royalties                      
Commitments                      
Period after first commercial sale         10 years            
Palatin Technologies, Inc. | Vyleesi Products | Achievement of Certain Annual Sales Milestones over Course of License Agreement                      
Commitments                      
Future contingent payments (up to)         $ 300,000            
Minimum                      
Commitments                      
Remaining operating lease term           1 year          
Minimum | Velo Bio, LLC | Annual Sales Milestone Achievements                      
Commitments                      
Sales milestone targets     300,000                
Maximum                      
Commitments                      
Remaining operating lease term           4 years          
Maximum | Velo Bio, LLC | Annual Sales Milestone Achievements                      
Commitments                      
Sales milestone targets     $ 900,000                
Lumara Health Inc.                      
Commitments                      
Contingent consideration (up to)                     $ 350,000
Business acquisition, contingent consideration, liability                   $ 50,000  
Lumara Health Inc. | Annual Net Sales Milestone                      
Commitments                      
Contingent consideration paid               150,000      
Accounting Standards Update 2016-02                      
Commitments                      
Operating lease, liability           $ 7,900   7,900 $ 8,500    
Operating lease, right-of-use asset           $ 7,000   $ 7,000 $ 7,600    
Perosphere Pharmaceuticals Inc.                      
Commitments                      
Contingent consideration (up to)   $ 365,000                  
Perosphere Pharmaceuticals Inc. | Regulatory Milestone Achievement                      
Commitments                      
Contingent consideration (up to)   $ 140,000                  
Credited percentage   50.00%                  
Perosphere Pharmaceuticals Inc. | Milestone Achievement, Approval By European Medicines Agency                      
Commitments                      
Contingent consideration (up to)   $ 40,000                  
Perosphere Pharmaceuticals Inc. | Sales Milestones Achievement                      
Commitments                      
Contingent consideration (up to)   225,000                  
Perosphere Pharmaceuticals Inc. | First Sales Milestone Achievement                      
Commitments                      
Contingent consideration, milestone payment   20,000                  
Potential milestone payment, triggering event, sales   $ 100,000